Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome

Published on :

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome October 31, 2019 07:30 ET | Source: NexImmune, Inc. IND clearance enables [….]

Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region 

Published on :

Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region February 26, 2019 For every AstraZeneca, there are hundreds of small biotech startups and scores of life science innovators that [….]

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

Published on :

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by [….]